The DEX implant can be an option in the case of contraindications to the use of anti-VEGF (as in the first 3 months after a heart attack/stroke), or poor compliance with the treatment regimen of anti-VEGF, or poor response to the anti-VEGF treatment after the loading dose. The gene discussed is VEGFA; the disease is stroke disorder.